Serum analysis has been considered in children since the 1990s, formerly as a candidate marker to screen for FH affected subjects [22,23], then to distinguish other dyslipidemias in subjects carrying ApoB exceeding 100 mg/dL levels [24]. The gene discussed is APOB; the disease is familial hyperaldosteronism.